Trade NRXS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Neuraxis, Inc. (NRXS) is trading at US$5.96, down 1.06% today as of Aug 28, 12:41 EDT. The company has a market capitalisation of US$77.23M. Over the past 52 weeks, NRXS has traded between US$2.21 and US$9.33. On Syfe you can trade NRXS with $0 commission and add it to your watchlist.
| Previous close | US$6.02 |
|---|---|
| Market cap | US$77.23M |
| 52-week range | US$2.21 – US$9.33 |
| Volume | 82.66K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Neuraxis, Inc.
NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
Year: 2023
Neuraxis, Inc. (NRXS) stock is trading at US$5.96, -1.06% from the previous close of US$6.02.
The market cap for Neuraxis, Inc. (NRXS) stock is approximately US$77.23M.
The 52-week high for Neuraxis, Inc. (NRXS) stock is US$9.33.
The 52-week low for Neuraxis, Inc. (NRXS) stock is US$2.21.
Neuraxis, Inc. (NRXS) does not currently pay a dividend.
Stay on top of NRXS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
